CaixaResearch Snapshot: A CaixaResearch study has made a major breakthrough in achieving personalised medicine for liver cancer
Published on 28/04/2025

More than 860 000 new cases of liver cancer are diagnosed worldwide each year and hepatocellular carcinoma is the most common form, as well as one of the leading causes of cancer-related mortality. This is a particularly complex disease as it occurs in four distinct subtypes, each with its own genetic alterations and molecular characteristics.
Until now, research has come up against a considerable hurdle: the lack of experimental models capable of faithfully reproducing such complexity. This limitation significantly hinders the development of new treatments as it’s not possible to predict how different patients will respond to drugs, thereby impeding progress towards more personalised therapies.
Now, a promising solution has been offered by new study,

